Barron's : Germany Takes a Hit With Iran War. These Stocks Might Still Be Bargai

Germany Takes a Hit With Iran War. These Stocks Might Still Be Bargains.

German Chancellor Friedrich Merz’s approval rating has plunged along with economic growth expectations.
The DAX 40 Index dropped 5% since Feb. 28, as Germany, vulnerable to energy shocks, faces a likely recession.
Despite challenges, investors eye oversold stocks like SAP and Rheinmetall—both down 30%—and defense/infrastructure plays.

The Iran war kicked Germany when it was trying to get up. There might still be stocks worth buying in Europe’s top economy and across the continent.

The moderate exuberance that prevailed a year ago as Friedrich Merz ascended to the chancellorship and Berlin released its constitutional “debt brake” has given way to gloom. The closely watched Ifo Business Climate Index plunged in April to its lowest level since pandemic days. Merz’s government cut 2026 economic growth expectations in half, to 0.5%.

Merz’s political honeymoon, such as it was, is definitively over. Polls show him as “the most unpopular chancellor in 30 years,” with approval around 20%, says Jeremie Peloso, chief strategist for Europe at BCA Research. His Social Democratic coalition partners have fallen further, to an “existential edge,” notes Carsten Brzeski, global head of macro for ING Research. “The verdict on this government’s ability to push reforms is unfortunately disappointing,” he says.

No wonder the DAX 40 Index of German stocks has dropped 5% since the U.S. and Israel attacked Iran on Feb. 28, while the S&P 500 index has gained more than 3%.

Germany’s economy is one of Europe’s most vulnerable to the latest energy shock because it has shifted more slowly away from fossil fuels and depends more on power-guzzling heavy industry. “Germany and the United Kingdom are the most likely European countries to fall into recession,” Peloso says.

Berlin has one whopping advantage, though: debt to gross domestic product at about half of its large neighbors’ levels. Merz’s promised “fiscal bazooka” is already cushioning the war damage by pumping euros into infrastructure and defense. More spending could follow in extremis.

Most importantly, equity investors buy companies, not countries, especially in an export powerhouse like Germany. One big German name that looks oversold is software giant SAP, says Michael Field, European equity strategist at Morningstar. Adding wartime decline to the preceding “SaaSpocalypse,” the shares have sunk 30% this year.

Field is also high on German armaments mainstay Rheinmetall, Morningstar’s top pick in a European defense sector that has counterintuitively declined as the U.S. depletes munitions in the Persian Gulf. Rheinmetall shares are likewise off 30% from a January peak.

Sebastian Schrott, portfolio manager for European equities at T. Rowe Price, has also “added to preferred defense names” as valuations drop. His most preferred is Norwegian missile maker Kongsberg Gruppen. He bought “a bit” of Rheinmetall, as well.

Schrott is betting on Merz’s infrastructure spree through SPIE, a French-domiciled specialist in energy and communications equipment that earns the largest chunk of its revenue in Germany. While Germany lacks headline artificial-intelligence names, it is deep in suppliers to utilities that are rushing to provide power for mushrooming data centers, Peloso points out. The outstanding example is Siemens Energy, whose shares have surged fivefold over the past 18 months, vaulting the company to No. 4 in the DAX.

Investors are conducting an “interesting debate” on whether the Iran war could actually be positive for European banks, Schrott says. With continental inflation tame, the European Central Bank looked to be headed prewar toward interest rates too low for lenders to earn healthy margins. The conflict has shifted expectations to two or three increases from the current benchmark rate of 2%, says Morningstar’s Field.

Shares in German flagship Deutsche Bank have cratered 20% this year. Another one to watch, maybe.

TechCrunch : Apple was surprised by AI-driven demand for Macs

Apple was surprised by AI-driven demand for Macs

Apple’s iPhone sales and Services revenue were the stars of the show in the tech giant’s most recent quarter, but the Mac quietly outperformed — helped by growing demand for AI workloads.
Wall Street investors had expected to see Mac revenue in the low $8 billion range, but Apple reported $8.4 billion in the second quarter ended March 28 — a notable beat for a non-core segment of the tech giant’s business. In addition, investors ahead of earnings believed that Mac sales would be essentially flat year-over-year. Instead, Mac sales were up 6% on an annual basis, the company told investors. The company’s total revenue was $111.2 billion, a 17% increase from the same period last year.

Apple chalked up some of the Mac growth to recent product launches, including the well-received MacBook Neo. However, those fun, colorful computers were only on sale for a few weeks after the March 4 preorders began. Realistically, most units shipped mid- to late March, and some demand may have been pushed into April as certain models sold out.
Apple CEO Tim Cook told analysts on the company’s Q2 earnings call on Thursday that customer demand for the Neo was “off the charts” and higher than Apple had expected. He also noted that Apple set a record in the quarter for customers new to the Mac, partly due to the Neo.
Cook attributed the Mac sales growth to the use of the platform for running local AI models, like OpenClaw — something that took Apple somewhat by surprise as Mac mini and Mac Studio devices sold out in recent weeks.
“Both of these are amazing platforms for AI and agentic tools, and the customer recognition of that is happening faster than what we had predicted, and so we saw higher than expected demand,” Cook said of these Mac sales. He also noted that the Mac mini was the top-selling desktop in China — a market that’s been in an OpenClaw frenzy as of late.
Still, Mac revenue was flat on a quarter-over-quarter basis, suggesting this new demand has yet to scale. Cook said it may take Apple “several months” to reach supply-demand balance on the Mac mini and Studio models.
“We’re not at the point where we’re saying this [constraint] is going to end anytime soon. And it’s not because of a problem, per se, other than we just under-called the demand,” Cook explained.
Enterprise demand for the Mac was also at play. Apple pointed to a couple of larger companies, including Perplexity, that had turned to Mac as their preferred platform for building enterprise-grade AI assistants.
He also said Apple was “supply constrained on the MacBook Neo,” and has even seen school systems, like Kansas City Public Schools, dropping Chromebooks for the Neo.

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Air Products (APD) upgraded to Outperform from Market Perform at BMO Capital, tgt $360
    • Caterpillar (CAT) upgraded to Equal Weight from Underweight at Morgan Stanley, tgt $915
    • Hershey (HSY) upgraded to Buy from Hold at TD Cowen, tgt $210
    • Pilgrim's Pride (PPC) upgraded to Overweight from Equal Weight at Barclays, tgt $42
    • Roblox (RBLX) upgraded to Hold from Sell at TD Cowen
    • TKO Group (TKO) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $225
    • WTW (WTW) upgraded to Outperform from Market Perform at BMO Capital, tgt $300
  • Downgrades:
    • Avis Budget (CAR) downgraded to Hold from Buy at Jefferies, tgt $160
    • Beacon Financial (BBT) downgraded to Market Perform from Strong Buy at Raymond James
    • e.l.f. Beauty (ELF) downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $67
    • KalVista (KALV) downgraded to Neutral from Buy at H.C. Wainwright, tgt $27
    • Methanex (MEOH) downgraded to Neutral from Overweight at JPMorgan, tgt $65
    • Roblox (RBLX) downgraded to Neutral from Buy at BofA Securities, tgt $48
    • Roblox (RBLX) downgraded to Market Perform from Outperform at Raymond James
    • Ryan Specialty (RYAN) downgraded to Equal Weight from Overweight at Wells Fargo, tgt $31
    • Sunbelt Rentals (SUNB) downgraded to Underweight from Neutral at JPMorgan, tgt $75
    • Truist Financial (TFC) downgraded to Neutral from Outperform at Robert W. Baird, tgt $55
  • Others:
    • Apogee Therapeutics (APGE) initiated with a Buy at Rothschild & Co Redburn, tgt $140
    • Arrowhead (ARWR) initiated with an Overweight at JPMorgan, tgt $88
    • Astera Labs (ALAB) initiated with a Neutral at Rothschild & Co Redburn, tgt $153
    • Celestica (CLS) initiated with a Buy at Rothschild & Co Redburn, tgt $460
    • Ciena (CIEN) initiated with a Neutral at Rothschild & Co Redburn, tgt $416
    • Coherent (COHR) initiated with a Buy at Rothschild & Co Redburn, tgt $455
    • Commvault (CVLT) initiated with a Peer Perform at Wolfe Research
    • Credo Technology (CRDO) initiated with a Buy at Rothschild & Co Redburn, tgt $206
    • Dutch Bros (BROS) initiated with an Outperform at Oppenheimer, tgt $72
    • Evommune (EVMN) initiated with a Buy at Stifel, tgt $54
    • Lumentum (LITE) initiated with a Buy at Rothschild & Co Redburn, tgt $1,270
    • Lyell Immunopharma (LYEL) initiated with an Outperform at Robert W. Baird, tgt $49
    • MGM Resorts (MGM) resumed with Hold from Buy at Jefferies, tgt $44
    • Paramount Skydance (PSKY) assumed at Overweight from Underweight at Morgan Stanley, tgt $14
    • Rubrik (RBRK) initiated with an Outperform at Wolfe Research, tgt $70
    • Septerna (SEPN) initiated with a Buy at Stifel, tgt $43
    • Suncrete (RMIX) initiated with a Buy at Jefferies, tgt $19
    • Toyota (TM) resumed with an Equal Weight at Morgan Stanley

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • RBLX -24.5%, SMMT -19.5%, ATMU -11.1%, INGM -9% (also increases dividend; also increases buyback auth by $100 mln), WDC -8.2% (also increases dividend), FND -6.8% (also authorizes new $400 mln share repurchase program), CLX -5.8%, SNDK -5.4%, RYAN -5.4%, IMAX -5.3%, TREE -5.2%, AXTI -5.1%, RIVN -4.9% (also files mixed shelf offering, also increasing production capacity to 300K vehicles at Stanton Springs), XHR -4.7%, ALHC -4.6%, RMD -4.5% (also CFO to retire; names new CFO), NSP -4.2%, MPWR -3.4%, SAM -3.1%, CUBE -3.1%, NWG -3%, DXCM -2.9%, BIO -2.9%, CABO -2.7%, SXI -2.6%, VRTS -2.3%, LAZ -2.2%, WNC -2.2%, MTX -2.1%, LOPE -2%, PWP -2%, DLB -1.9%, AN -1.9%, SNDX -1.8%, AMGN -1.8%, CNK -1.8%, DINO -1.7%, POR -1.6%, LYB -1.5%, EXPO -1.3% (also authorizes new $50 mln share repurchase program), LPLA -1.2% (also resumes share repurchase program), EAF -1.2%, EGO -1.1%, CNO -1.1%, LNT -1%
Other news:
  • SENS -18.3% (prices $80 mln equity offering at $5.00 per share)
  • GRO -15.8% (stock offering)
  • NIO -2.7% (April deliveries)
  • TLSA -1.9% (to delay 20-F filing)
  • MTRX -1.5% (CFO to step down)
  • AZN -1.3% (Truqap recommended by FDA Advisory Committee; provides update on FDA Advisory Committee vote on camizestrant in combination with a CDK4/6 inhibitor; faces setback)
  • IE -1.2% (files mixed securities shelf offering)
  • EQNR -1.1% (files mixed securities shelf offering)
  • AMKR -1.1% (prices offering of 1.0 bln of 0.00% convertible senior notes due 2031)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • TEAM +22.4%, TWLO +17.6%, WEAV +16.5%, FIVN +14.9% (also $90 mln accelerated share repurchase; new $200 mln share repurchase program), RDDT +13.9%, NVT +10.6%, EL +9.9%, BOOM +9.8%, CERS +9%, TRUP +8.4%, ROKU +8.1%, MATW +7.3%, MRNA +6.4%, ZETA +6.3%, MTZ +5.4%, SBGI +5.1%, PRLB +4.9%, DBVT +4.8%, HUN +4.7%, GDDY +4%, NEWT +3.9%, JAKK +3.9%, MMSI +3.9%, ENSG +3.8%, HG +3.8%, AAPL +3.7% (also increases dividend 4%; authorizes additional program to repurchase up to $100 bln of common stock), OLED +3.5% (also authorizes new $400 mln share repurchase program), EBS +3.4%, CHD +3.4%, KIDS +3.3%, COLM +3.2%, ALGT +3.1%, BTSG +3%, HR +2.9%, SNDR +2.9%, NWL +2.9%, TEX +2.9%, ACA +2.8%, CVEO +2.6%, AON +2.6%, AMG +2.5%, RIOT +2.4%, LEA +2.3%, ACCO +2.2%, EMN +2%, DRH +2% (also authorizes new $300 mln share repurchase program), MGA +2%, CL +2%, GDYN +1.8%, TRP +1.8%, SHEN +1.7%, SPSC +1.6%, PK +1.6%, PSO +1.5%, ARES +1.2%, KWR +1.1%
Other news:
  • VEEV +9.8% (to join S&P 500)
  • MFI +3.6% (to delay 20-F filing)
  • TWO +3.3% (UWMC issues open letter to Two Harbors stockholders detailing new $12 per share offer)
  • CTNM +3% (reports topline data from PIPE-791 phase 1b trial)
  • MPLT +2.7% (announces completion of enrollment in ZEPHYR phase 2 trial and updates expected timing of topline results)
  • GEN +1.9% (launches VPN for Agents)
  • RYTM +1.9% (confirms that the EC expanded the marketing authorization for IMCIVREE (setmelanotide) to include the treatment of obesity and control of hunger in adults and children 4 years of age and above with acquired hypothalamic obesity due to hypothalamic injury or impairment)
  • XE +1.7% (PPL units and XE are collaborating to explore deploying Xe-100 small modular reactor in Kentucky)
  • BHR +1.7% (to sell the Park Hyatt Beaver Creek Resort)
  • CHCT +1.7% (raises quarterly dividend to $0.48 per share)
  • CWT +1.7% (California Water Service receives CPUC rate case decision, approves increases)
  • TXT +1.2% (selected by Near Earth Autonomy as a partner)

The Information : Apple's Cash Strategy Shift

Apple's Cash Strategy Shift

Tim Cook is going out with a bang. Apple reported a stellar March quarter on Thursday, delivering 17% higher revenue, thanks to 22% growth in iPhone revenues, a big change from several years of anemic growth in sales of the ubiquitous device. In other words, far more consumers are upgrading their old iPhones than has been the case for a while.

Cook, who recently announced he would step down as CEO—to be succeeded by hardware executive John Ternus—on Sept. 1, was as ebullient as ever on Thursday’s call. As is the Apple way, he and Ternus traded over-the-top compliments. Ternus described Cook as “one of the greatest business leaders of all time,” while Cook gushed, “There is no one on this planet I trust more to lead Apple into the future than John Ternus.” Even before Cook steps down, though, Apple is making some big changes.

For one thing, as Cook pointed out on an earnings call, the company increased its research and development spending 34% in the quarter, reflecting investments to take advantage of “opportunities we see in both” products and services, Cook said. Apple has never been known for its lavish R&D expenditures—as a percentage of revenues, its R&D expense has hovered around 8% in the past few years, about half that of Google parent Alphabet. With AI transforming tech and expected to usher in a new generation of devices, Apple clearly doesn’t want to be left behind.

In the same vein, Apple Chief Financial Officer Kevan Parekh revealed on an analyst call that the company was abandoning its long-standing cash management strategy of aiming to be “net cash neutral"—which means having equal amounts of cash and debt on the balance sheet. Introduced in 2018 under former CFO Luca Maestri and Cook, that philosophy underpinned consistently massive stock buybacks. Apple’s net cash—cash on the balance sheet after deducting debt—shrank to $62 billion as of March 31, from $163 billion when the target was announced in 2018.

Parekh didn’t explain the change of heart in meaningful language—preferring corporate blather—but the shift raises the prospect that Apple wants to stockpile cash more than it has been doing. While it raised its dividend and announced a new buyback program, the company cut its stock buybacks in half in the March quarter from the year-earlier period, even though free cash flow jumped 28% compared with that period. (Parekh hinted that the quarter's buyback reduction was related to the announcement of the CEO transition: Much speculated about beforehand, it possibly contributed to volatility in Apple stock.)

Why would Apple want to keep more cash on hand? It‘s possible Cook and Ternus want to be prepared for skyrocketing memory chip prices, which Cook hinted he was expecting. But stockpiling cash could position Apple well at a time its counterparts in big tech are running down their cash reserves dramatically with massive capital expenditures. Imagine what assets might come up for sale, for instance, that other companies won’t have the money to buy? Of course, Apple historically hasn’t done major acquisitions. But it’s possible the next few years will bring more radical changes to the company than might now be apparent.